What's reshaping the future of modern therapeutics? Across novel modalities, targeted therapies and drug resistance research, breakthroughs keep emerging rapidly.
We are heading to EFMC Medicinal Chemistry 2026 in Basel, where we'll present three scientific posters featuring our latest advances on transformative platforms and approaches in modern drug discovery:
✅ RIPTAC platform linking target engagement to selective cancer cell killing
✅ Drug-resistant cell panel for KRAS resistance solutions
✅ STAT6: A transcription driver in type 2 immunity and a rising therapeutic target
Join us at Booth #33 and dive into our featured posters. Let's discuss how our integrated drug discovery platform can accelerate your programs.
Location: Basel, Switzerland
Date: September 6-10, 2026
Booth: #13
PREV：Unlock Next-Gen Oncology Therapies with ...
NEXT：There's no more
2026-07-10
2026-06-15
2026-05-29
2026-05-28
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
Get a quote
Go top
